ENDODERMA
COMPANY
IP & RECOGNITION
HIGHLIGHTS
  HOME   >   ENDODERMA   >   HIGHLIGHTS
ENDODERMA CO.,LTD. is the edge leader in bio-cosmetics based on microneedle technology and Transdermal Drug Delivery System(TDDS).
Successfully acomplished Korean Government funded project worth of US$ 4.5M R&D on microneedle vaccine patches for hepatitis B and shingles.
IPs on the world-first microneedle patch with CLHA(cross-linked hyaluronic acid). CLHA has been clinically proven to significantly reduce wrinkles, up to 7days per treatment thanks to long half-life.
DBO of TDDS platform with comprehensive dermal solutions to industries by developing a wide spectrum of cosmeceutical products covering wrinkles, vitamid C for anti-oxidation, EGF for skin nutrition and regeneration, acne, freckles and dark circles.
All functional features of our technology has been clinically proven by renowned university hospitals.
Fully automated GMP and ISO certified factory assures the edge quality of all products.
Currenlty in sales over dozens of countries including US, Japan, Germany, Australia, Thailand, Phillipines, and others.
From Cosmetics Microneedle Patches to Drug and TDDS, ENDODERMA CO.,LTD. is at the very edge of the skin science and transdermal delivery platform.
Cosmetics
Medical
Devices
Digital
Microneedles
Drugs
Functional Cosmetics (Approval by KFDA)
Medical Devices
Digital Microneedles (Electric Medicine)
Drug Delivery and microneedle sensing (bio-marker)
Transdermal Platform: NK cell embrio, stemcell, frequancies, wave, microshock…,etc
Consistently getting the same positive feedbacks on our product from all our clients!
ENDODERMA CO, LTD genuine microneedles, unlike other microneedles that have pain and skin avoidance effects, are produced in a pyramid shape, painless and far more effective, and last longer with CLHA.